The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...

ANIP is expected to raise 2025 guidance due to FDA approval and launch of TEZRULY and INZIRQO, addressing unmet needs for ...

He asked if there were any drugs or drug paraphernalia in her vehicle ... piece with white powder residue under the passenger side of the bench seat and two used syringes inside a black backpack next ...

The US Food and Drug Administration (FDA) has approved a pre-filled syringe version of argenx’s Vyvgart, giving generalised myasthenia gravis (gMG) and chronic inflammatory demyelinating ...

A disposal drop-off for prescriptions and syringes will take place Saturday, April 26, from 10 a.m. to noon at the Jefferson County Health Department, 715 Green Road, Madison. Proper disposal of ...

Novo Nordisk (NYSE:NVO) has filed for U.S. approval of an oral version of its blockbuster weight loss drug Wegovy, the company confirmed to BioPharma Dive. The Danish drugmaker disclosed the ...

A research team led by scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) made a major breakthrough with the potential to turn IV drugs into oral ...

That doesn’t seem consistent with firing Food and Drug Administration (FDA) facility inspectors and the staff in the policy division of the FDA Office of Generic Drugs, the office that develops ...

today announced that the U.S. Food and Drug Administration (FDA) has updated the U.S. Prescribing Information for CAMZYOS® (mavacamten, 2.5 mg, 5 mg, 10 mg, 15 mg capsules), simplifying treatment ...

Kennedy Jr., laid off the 17-person team in charge of the National Survey on Drug Use and Health ... The department’s Administration for Children and Families is weeks behind on the annual ...

1,3 Additionally, CAMZYOS is no longer contraindicated with moderate CYP2C19 inhibitors and strong CYP3A4 inhibitors, which were adjusted to drug interactions. This provides physicians with greater ...

April 17 (UPI) --People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug ... taking an oral pill instead of using needles and syringes.